Focus on Rare Diseases Novelion Therapeutics specializes in developing therapies for rare diseases, creating opportunities to target niche markets with high unmet medical needs, especially for conditions like homozygous familial hypercholesterolemia and inherited retinal diseases.

International Partnership Potential The company's existing licensing agreements with partners such as Recordati in Japan indicate a openness to global collaborations, providing opportunities to establish new distribution channels in additional markets for their orphan drug portfolio.

Pipeline Development With ongoing clinical development of zuretinol acetate and a focus on innovative science, there is potential to expand their product offerings and identify new sales opportunities within the rare disease treatment arena.

Market Expansion Strategy Recent acquisition activities and licensing deals demonstrate a strategic focus on expanding market reach through partnerships, which can be leveraged for joint sales efforts and co-marketing initiatives in targeted regions.

Financial Strength for Growth With a recent $50M debt financing and recent management hires, Novelion shows financial momentum that can support sales expansion, product launches, and increased investment in commercialization efforts for their therapies.